Sunday, August 31, 2008

Homes, Pesticides & Neuroblastoma

Neuroblastoma Linked to Homes Treated with Pesticides

SOURCE: Epidemiology: 12(1):20-26, January, 2001

One of the largest studies to date has found that pesticide use around the home can more than double the chance of a child developing neuroblastoma.

Neuroblastoma accounts for approximately 10% of all childhood tumors. There are 550 new cases in the United States each year, with an annual incidence rate of 9.2 cases per million children under 15 years of age. This works out to approximately 1 per 100,000 children under age 15 on a national level. (These rates were reported in the book "Principles and Practice of Pediatric Oncology, Lippincott-Raven, 1997). It is a very serious cancer as approximately 60% of children over age 1 who develop neuroblastoma do not live 3 years even when receiving treatments of radiation and chemotherapy. Children under age 1 have a more positive prognosis. As statistics show that neuroblastoma rates have increased over the past 50 years, it is reasonable to assume environmental factors may be involved.

One of the largest collaborative efforts among 7 Universities and medical facilities worked together to determine what extent pesticide use in the home could increase child neuroblastoma rates. 390 neuroblastoma children and 460 non-cancer controls were included in the study. Investigators questioned both parents regarding use of pesticides in and around the home.

Results showed that using pesticides in and around the home resulted in a 60% increased likelihood of children developing the disease (Odds Ratio=1.6). Looking at pesticide use for the lawn and garden only resulted in an increased risk of 120% (Odds Ratio=2.2) when the mother had applied pesticides in the yard and 50% higher (Odds Ratio=1.5) when the father had applied pesticides in the yard.

(Chem-Tox Note: Outdoor pesticides are much different from indoor pesticides as they include fungicides and herbicides some of which have been reported to contain dioxin).

Julie L. Daniels, Andrew F. Olshan, Kay Teschke, Irva Hertz-Picciotto, Dave A. Savitz, Julie Blatt, Melissa L. Bondy, Joseph P. Neglia, Brad H. Pollock, Susan L. Cohn, A. Thomas Look, Robert C. Seeger, Robert P. Castleberry
Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, University of British Columbia, University of Texas, University of Minnesota, University of Florida, Northwestern University, Department of Experimental Oncology, St. Jude Children's Research Hospital and University of Alabama


No comments: